American Oncology Network Inc. Market Cap ($325.24 Million)
Market Cap & Net Worth: American Oncology Network Inc. (AONC)
American Oncology Network Inc. market cap. American Oncology Network Inc. (NASDAQ:AONC) has a market capitalization of $325.24 Million ($325.24 Million) as of November 1, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #14129 globally and #3400 in its home market, demonstrating a 11.31% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying American Oncology Network Inc.'s stock price $11.12 by its total outstanding shares 29248362 (29.25 Million). Also see AONC cash flow metrics for how efficiently the company converts equity into cash flow.
American Oncology Network Inc. Market Cap History (2021–2026)
American Oncology Network Inc. market cap history from 2021 to 2026. Data shows growth from $285.17 Million to $325.24 Million (2.82% CAGR). Check today's stock price for American Oncology Network Inc. for real-time trading data and today's change.
American Oncology Network Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how American Oncology Network Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore AONC net assets growth trend to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.08x
American Oncology Network Inc.'s market cap is 0.08 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $285.17 Million | $943.75 Million | -$105.00K | 0.30x | N/A |
| 2022 | $293.80 Million | $1.15 Billion | $2.59 Million | 0.26x | 113.48x |
| 2023 | $172.57 Million | $1.28 Billion | -$5.54 Million | 0.13x | N/A |
| 2024 | $148.00 Million | $1.76 Billion | -$3.97 Million | 0.08x | N/A |
Competitor Companies of AONC by Market Capitalization
Companies near American Oncology Network Inc. in the global market cap rankings as of November 1, 2026. Also see total assets of American Oncology Network Inc. for a full breakdown of the balance sheet.
Key companies related to American Oncology Network Inc. by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #284 globally with a market cap of $91.34 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #901 globally with a market cap of $29.19 Billion USD ( €24.97 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #987 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Tenet Healthcare Corporation (NYSE:THC): Ranked #1210 globally with a market cap of $20.93 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #284 | HCA Healthcare, Inc. | NYSE:HCA | $91.34 Billion | $473.19 |
| #901 | Fresenius SE & Co. KGaA | XETRA:FRE | $29.19 Billion | €47.80 |
| #987 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1210 | Tenet Healthcare Corporation | NYSE:THC | $20.93 Billion | $273.25 |
Market Capitalization of American Oncology Network Inc. (2021–2026)
Market capitalization of American Oncology Network Inc. from 2021 to today. Between 2021 and today, American Oncology Network Inc.'s market cap moved from $285.17 Million to $ 325.24 Million, with a yearly change of 2.82%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $325.24 Million | -7.33% |
| 2025 | $350.98 Million | +137.15% |
| 2024 | $148.00 Million | -14.24% |
| 2023 | $172.57 Million | -41.26% |
| 2022 | $293.80 Million | +3.03% |
| 2021 | $285.17 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of American Oncology Network Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $325.24 Million USD |
| MoneyControl | $325.24 Million USD |
| MarketWatch | $325.24 Million USD |
| marketcap.company | $325.24 Million USD |
| Reuters | $325.24 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About American Oncology Network Inc.
American Oncology Network, Inc., through its subsidiaries, provides oncology management services in the United States. The company provides various services to patients, including laboratory services for routine and specialized testing; in-house professional and technical pathology services with pathology reports; in-house specialty pharmacy services with patient education, financial assistance, … Read more